A Clinical Trial of MK-2010 Alone and With Other Treatments in Participants With Advanced Solid Tumors (MK-2010-002)

Exclusion criteria

• Has a history of Kaposi's sarcoma and/or Multicentric Castleman's Disease if diagnosed with HIV • Has a history of posterior reversible encephalopathy syndrome (PRES) or seizure disorder • Has hepatic encephalopathy, hepatorenal syndrome, or Child-Pugh class B or more severe liver cirrhosis • Has a history of confirmed inflammatory bowel disease • Has a serious active nonhealing wound, ulcer, and/or bone fracture • Has a history of myocarditis or cardiomyopathy • Has a history of or current severe cardiovascular and cerebrovascular diseases • Is currently receiving any anticoagulants • Has a diagnosis of immunodeficiency • Has a known additional malignancy that is progressing or required active treatment within the past 3 years • Has known active central nervous system metastases and/or carcinomatous meningitis • Has active autoimmune disease that required systemic treatment in the past 2 years (hormonal supplementation \[eg, thyroxine, insulin, or physiologic corticosteroid\] is allowed) • Has a history of (noninfectious) pneumonitis/interstitial lung disease (ILD) that required steroids or has current pneumonitis/ILD • Has a history of stem cell/solid organ transplant • Has not adequately recovered from major surgery or from central venous access device placement, or has ongoing surgical complications